Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Trinity Biotech

    NASDAQ: TRIB · Real-Time Price · USD
    0.73
    0.05 (7.67%)
    At close: Jun 27, 2025, 3:36 PM

    Trinity Biotech Statistics

    Share Statistics

    Trinity Biotech has 18.59M shares outstanding. The number of shares has increased by 48.8% in one year.

    Shares Outstanding

    n/a
    		 18.59M

    Shares Change (YoY)

    n/a
    		 48.8%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 1.26%

    Shares Floating

    n/a
    		 18.57M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,990

    FTD / Avg. Volume

    n/a
    		 0.25%

    Short Selling Information

    The latest short interest is 37.69K, so 0.2% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 37.69K

    Short % of Shares Out

    n/a
    		 0.2%

    Short % of Float

    n/a
    		 0.28%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.69 and the forward PE ratio is -0.7. Trinity Biotech's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.69

    Forward PE

    n/a
    		 -0.7

    PS Ratio

    n/a
    		 0.29

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 -0.69

    P/FCF Ratio

    n/a
    		 -1.15

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Trinity Biotech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.6, with a Debt / Equity ratio of -2.82.

    Current Ratio

    n/a
    		 2.6

    Quick Ratio

    n/a
    		 1.27

    Debt / Equity

    n/a
    		 -2.82

    Debt / EBITDA

    n/a
    		 -2.8

    Debt / FCF

    n/a
    		 -4.73

    Interest Coverage

    n/a
    		 -2.67

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $149,557.89

    Profits Per Employee

    n/a
    		 $-63,205.26

    Employee Count

    n/a
    		 380

    Asset Turnover

    n/a
    		 0.96

    Inventory Turnover

    n/a
    		 1.88

    Taxes

    Income Tax

    n/a
    		 -59K

    Effective Tax Rate

    n/a
    		 0.16%

    Stock Price Statistics

    The stock price has increased by -67.31% in the last 52 weeks. The beta is 0.81, so Trinity Biotech's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.81

    52-Week Price Change

    n/a
    		 -67.31%

    50-Day Moving Average

    n/a
    		 0.69

    200-Day Moving Average

    n/a
    		 0.98

    Relative Strength Index (RSI)

    n/a
    		 51.49

    Average Volume (20 Days)

    n/a
    		 792,582

    Income Statement

    In the last 12 months, Trinity Biotech had revenue of 56.83M and earned -24.02M in profits. Earnings per share was -3.14.

    Revenue

    n/a
    		 56.83M

    Gross Profit

    n/a
    		 19.45M

    Operating Income

    n/a
    		 -27.05M

    Net Income

    n/a
    		 -24.02M

    EBITDA

    n/a
    		 -24.1M

    EBIT

    n/a
    		 -25.87M

    Earnings Per Share (EPS)

    n/a
    		 -3.14
    Full Income Statement

    Balance Sheet

    The company has 3.69M in cash and 67.43M in debt, giving a net cash position of -63.74M.

    Cash & Cash Equivalents

    n/a
    		 3.69M

    Total Debt

    n/a
    		 67.43M

    Net Cash

    n/a
    		 -63.74M

    Retained Earnings

    n/a
    		 -48.64M

    Total Assets

    n/a
    		 97.45M

    Working Capital

    n/a
    		 18.02M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -11.56M and capital expenditures -803K, giving a free cash flow of -14.26M.

    Operating Cash Flow

    n/a
    		 -11.56M

    Capital Expenditures

    n/a
    		 -803K

    Free Cash Flow

    n/a
    		 -14.26M

    FCF Per Share

    n/a
    		 -0.09
    Full Cash Flow Statement

    Margins

    Gross margin is 34.22%, with operating and profit margins of -47.59% and -42.26%.

    Gross Margin

    n/a
    		 34.22%

    Operating Margin

    n/a
    		 -47.59%

    Pretax Margin

    n/a
    		 -64.98%

    Profit Margin

    n/a
    		 -42.26%

    EBITDA Margin

    n/a
    		 -42.4%

    EBIT Margin

    n/a
    		 -47.59%

    FCF Margin

    n/a
    		 -25.09%

    Dividends & Yields

    TRIB pays an annual dividend of $2.2, which amounts to a dividend yield of 1.23%.

    Dividend Per Share

    n/a
    		 $2.20

    Dividend Yield

    n/a
    		 1.23%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 -122.22%

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for TRIB.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 23, 2024. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Feb 23, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 -0.48

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist